[prMac.com] New York, New York - Polymash Inc. has designed a free tool for individuals or small businesses who want to publish apps, but don't know where to start. The tool is especially helpful for people with good content, for example: published authors or aspiring authors; consultants or trainers with their own unique subject matter or methodology; photographers and videographers; professional practitioners in health and fitness, wellness, education, human sciences to name just a few.
The Mobile Readiness tool covers six dimensions of readiness that, once completed, produce clarity for the individual about their current state of mobile readiness. The report it generates provides invaluable tips to help kick-start a mobile strategy. The tool's intention is to provide a very real look at what it takes. The tool helps the individual (or business) to:
* Translate great ideas and visions into a real actions * Identify existing strengths as a starting point * Think strategically about the six dimensions covered in the tool and the alignment between each * Appreciate what it takes to offer engaging end user experiences wherever users are * Clarify their market, the resources needed and marketing effort required * Inform themselves about current mobile trends globally * Learn about the different app market places and devices
Polymash draws on data sets from its own experience and a cross-section of mobile media and technology research organizations, resulting in a white paper with the most up-to-date facts and mobile trends in 2012.
After two years of building relationships and educating content owners, and with nine successful apps and a #2 ranked app in the Business category on iTunes, the Polymash team has been able to distill the key drivers of successful app creation to six major dimensions.
Their self assessment tool realistically shows what it takes to make a successful app in a still relatively new, yet rapidly growing market place. The self-assessment is not for the faint-hearted. Yet, with good content, a strong desire and a blend of realism and strategic effort, Polymash states that with their guided approach, the chances of producing successful apps for content owners and their users is very high.
Polymash Inc. is a US-based boutique creative agency whose mission is to transform knowledge and content into exceptional experiences on web and emerging mobile platforms, offering a full range of mobile, app creation and mobile marketing services with a strength in integrating the artistic, human and technological dimensions to all projects. Copyright (C) 2012 Polymash Inc. All Rights Reserved. Apple, the Apple logo, iPhone, iPod and iPad are registered trademarks of Apple Inc. in the U.S. and/or other countries.
Tags: graphic design, internet applications, php development, php programming, search engine optimization, seo, web applications, web design, web development, web hosting, web programming
If you have a positive attitude, you will find it much easier to manifest your desires, as you will be naturally giving out positive emotional thought vibrations which will attract positive things to you. Even if you are not consciously trying to manifest something, your positive attitude will naturally attract more things to be positive about and you will be one of those people who seem to attract endless good fortune.
Try to remain positive at all times. This doesn?t mean you can never feel down or can never again have a good old moan, but you have to make your natural state as positive and as upbeat as possible. Get out of the habit of complaining about certain situations in your life. Stop any negative self talk, such as Oh I?ll never be able to do that?. Expect that good things will happen to you and that every outcome will be positive.
If something unwanted happens, try to see a positive side to it if you can. For example, if you moan that every time you have a little extra money, your car needs repairs or you receive an unexpected bill, try turning it around and start being thankful that you have the extra money to allow you to pay for these unexpected expenses.
I heard about someone whose car required so many repairs it was not economically worth repairing. He couldn?t afford to replace it, so decided he would have to go without a car until he had saved the money for a new one. He started cycling to work, and after a few months realized that he had lost two stones in weight and was enjoying cycling so much he decided to take it up competitively. So from not being able to afford a new car, he became fit and healthy and found a new hobby!
Always get into the habit of looking for the positive side to your problems.
Unfortunately our natural state is to feel either negative or at best in a state of what I call flat- neither unhappy but not particularly great either. It is very difficult to attract positive things into your life by feeling flat, as you are shutting yourself off from vibrating at a higher level; these vibrations flow best when you are feeling happy, positive and good about yourself.
Do more of the things that bring you joy, for whenever you feel joy, happiness and love you are connected most strongly to your higher self. Chat to your partner, laugh with your children, stroke or play with your pet. Meet up with a friend for coffee and have a laugh. Listen to your favorite music, or music that calms, relaxes or inspires you, or watch a television show that motivates you or makes you laugh.
Place pictures of your family, your pets or of you enjoying a favorite hobby around your home and place of work. Looking at them should help you to feel instantly more positive and full of love.
Exercise can be a great mood lifter. Even a gentle walk can raise your spirits and boost your energy levels.
Nobody can feel happy all of the time, although feeling upbeat becomes easier the more you practice it, but start by finding things to feel great about in your life; laugh more, moan less, hang around with positive, upbeat people and try to avoid negative folk. Expect that things will turn out well and that if you experience a problem you will find a solution. Expect good things to come your way!
Not only will you start to attract many more good things than bad into your life, but you will be much more open to receiving your intentions.
Chemicals today, drugs tomorrow: U-M's new Center for Drug DiscoveryPublic release date: 29-Aug-2012 [ | E-mail | Share ]
Contact: Laura J. Williams lauralw@umich.edu 734-615-4862 University of Michigan
ANN ARBOR, Mich.-- A new center at the University of Michigan will accelerate the progression to the marketplace of drugs under development at laboratories across campus.
Called the Center for the Discovery of New Medicines (CDNM), it will coordinate and support work in a range of departments and schools to streamline drug discovery and development, support the translation of early research toward patient usea gray area where funding is scarceand fully leverage the technical capabilities and intellectual resources at U-M in service of discovering the therapies of tomorrow.
"The CDNM will be a central hub for a dynamic community of researchers working on cures for devastating diseases," said Phil Hanlon, U-M povost and executive vice president for academic affairs. "Making collaborations possible and offering expert guidance throughout the process will catalyze activity in this area."
Funding for early stage drug discoveryidentifying pathways involved in disease and finding ways to interact with those pathwayshas declined in the pharmaceutical industry. The National Institutes of Health has recently increased funding for translational research, but the investment is insufficient and many projects frequently languish without the financial support to conduct the next stage of development.
The CDNM is a virtual organization founded by multiple schools and departments at U-M that are involved in biomedical research. Through rapid-access seed grants and twice-yearly pilot grant competitions, the CDNM will fund crucial steps in the drug discovery process while linking facilities that are currently unconnected.
"There is a lot of exciting work happening in drug discovery at U-M, but it's fragmented," said Rick Neubig, professor of pharmacology and director of the CDNM. "By marrying the power of chemical diversity with the broad reach and expertise of Michigan biologists, we expect a big impact."
Disease areas in which U-M is making the most immediate progress are cancer, inflammation, orphan and metabolic diseases and neurodegeneration, Neubig said.
The participating organizations at U-M pooled about $500,000 a year for the next three years to distribute as grants. Neubig expects the CDNM will fund 10 to 15 projects a year. Tenure-track and research-track faculty members at U-M will be able to apply. Applications for the first round of grants are due Oct. 1.
"The NIH is increasingly awarding its research funding to translational areas like innovative pharmacology and drug discovery," said Dr. James O. Woolliscroft, dean of the U-M Medical School. "The center will help position us to compete for this funding."
The CDNM will also be a hub to connect U-M researchers with commercial partners and foundations, Neubig said, adding that he expected the CDNM to help stimulate the region's economy.
"The CDNM can really maximize the potential for academic drug discovery at U-M and accelerate the discovery of new therapeutics," said David Sherman, the Hans W. Vahlteich Professor of Medicinal Chemistry and associate dean for research and graduate education in U-M's College of Pharmacy and a Life Sciences Institute faculty member. "We hope this work will lead to increased business development around drug discovery, which has the potential ripple throughout the industry and the region."
The CDNM is distinguished from academic drug discovery efforts at other institutions by the breadth and depth of U-M's biomedical research, its capabilities in areas like medicinal chemistry and pharmacokinetics that are traditionally associated with the pharmaceutical industry, unique natural product extract libraries and a data-sharing system that increases efficiency and supports collaboration.
"Universities play a critical and growing role in early-stage drug discovery," said Dr. Jeff Leiden, chairman, CEO and president of Vertex Pharmaceuticals. "The work of academic researchers who are identifying and testing promising new targets and compounds is an important step in developing new breakthrough drugs for serious diseases. Collaborations between academic groups and biotech companies are increasingly important in discovering the next generation of transformational medicines."
U-M has the technological infrastructure critical to early stage drug development, but because the scientists working in this area are spread throughout the university, collaboration is sometimes difficult.
"We've seen firsthand the progress than can be made when scientists are able to work together spontaneously and smoothly," said Alan Saltiel, the Mary Sue Coleman Director of the Life Sciences Institute. "The CDNM will make it possible for scientists with promising discoveries to work together in new and highly productive ways to further develop potential treatments."
###
Funding for the CDNM has been provided by the College of Pharmacy, Comprehensive Cancer Center, Department of Internal Medicine, Department of Pathology, Endowment for the Basic Sciences, Life Sciences Institute, Medical School Office of Research and the Michigan Institute for Clinical and Health Research. For more information, visit cdnm.lsi.umich.edu.
[ | E-mail | Share ]
?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
Chemicals today, drugs tomorrow: U-M's new Center for Drug DiscoveryPublic release date: 29-Aug-2012 [ | E-mail | Share ]
Contact: Laura J. Williams lauralw@umich.edu 734-615-4862 University of Michigan
ANN ARBOR, Mich.-- A new center at the University of Michigan will accelerate the progression to the marketplace of drugs under development at laboratories across campus.
Called the Center for the Discovery of New Medicines (CDNM), it will coordinate and support work in a range of departments and schools to streamline drug discovery and development, support the translation of early research toward patient usea gray area where funding is scarceand fully leverage the technical capabilities and intellectual resources at U-M in service of discovering the therapies of tomorrow.
"The CDNM will be a central hub for a dynamic community of researchers working on cures for devastating diseases," said Phil Hanlon, U-M povost and executive vice president for academic affairs. "Making collaborations possible and offering expert guidance throughout the process will catalyze activity in this area."
Funding for early stage drug discoveryidentifying pathways involved in disease and finding ways to interact with those pathwayshas declined in the pharmaceutical industry. The National Institutes of Health has recently increased funding for translational research, but the investment is insufficient and many projects frequently languish without the financial support to conduct the next stage of development.
The CDNM is a virtual organization founded by multiple schools and departments at U-M that are involved in biomedical research. Through rapid-access seed grants and twice-yearly pilot grant competitions, the CDNM will fund crucial steps in the drug discovery process while linking facilities that are currently unconnected.
"There is a lot of exciting work happening in drug discovery at U-M, but it's fragmented," said Rick Neubig, professor of pharmacology and director of the CDNM. "By marrying the power of chemical diversity with the broad reach and expertise of Michigan biologists, we expect a big impact."
Disease areas in which U-M is making the most immediate progress are cancer, inflammation, orphan and metabolic diseases and neurodegeneration, Neubig said.
The participating organizations at U-M pooled about $500,000 a year for the next three years to distribute as grants. Neubig expects the CDNM will fund 10 to 15 projects a year. Tenure-track and research-track faculty members at U-M will be able to apply. Applications for the first round of grants are due Oct. 1.
"The NIH is increasingly awarding its research funding to translational areas like innovative pharmacology and drug discovery," said Dr. James O. Woolliscroft, dean of the U-M Medical School. "The center will help position us to compete for this funding."
The CDNM will also be a hub to connect U-M researchers with commercial partners and foundations, Neubig said, adding that he expected the CDNM to help stimulate the region's economy.
"The CDNM can really maximize the potential for academic drug discovery at U-M and accelerate the discovery of new therapeutics," said David Sherman, the Hans W. Vahlteich Professor of Medicinal Chemistry and associate dean for research and graduate education in U-M's College of Pharmacy and a Life Sciences Institute faculty member. "We hope this work will lead to increased business development around drug discovery, which has the potential ripple throughout the industry and the region."
The CDNM is distinguished from academic drug discovery efforts at other institutions by the breadth and depth of U-M's biomedical research, its capabilities in areas like medicinal chemistry and pharmacokinetics that are traditionally associated with the pharmaceutical industry, unique natural product extract libraries and a data-sharing system that increases efficiency and supports collaboration.
"Universities play a critical and growing role in early-stage drug discovery," said Dr. Jeff Leiden, chairman, CEO and president of Vertex Pharmaceuticals. "The work of academic researchers who are identifying and testing promising new targets and compounds is an important step in developing new breakthrough drugs for serious diseases. Collaborations between academic groups and biotech companies are increasingly important in discovering the next generation of transformational medicines."
U-M has the technological infrastructure critical to early stage drug development, but because the scientists working in this area are spread throughout the university, collaboration is sometimes difficult.
"We've seen firsthand the progress than can be made when scientists are able to work together spontaneously and smoothly," said Alan Saltiel, the Mary Sue Coleman Director of the Life Sciences Institute. "The CDNM will make it possible for scientists with promising discoveries to work together in new and highly productive ways to further develop potential treatments."
###
Funding for the CDNM has been provided by the College of Pharmacy, Comprehensive Cancer Center, Department of Internal Medicine, Department of Pathology, Endowment for the Basic Sciences, Life Sciences Institute, Medical School Office of Research and the Michigan Institute for Clinical and Health Research. For more information, visit cdnm.lsi.umich.edu.
[ | E-mail | Share ]
?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
AUGUSTA, Maine (AP) ? Maine environmentalists celebrated the adoption of new federal regulations that will nearly double the average gas mileage of new cars and trucks by 2025, calling them a major step toward reducing global warming while saving consumers hundreds of millions of dollars in reduced fuel costs.
"Future generations may well look back on today as a decisive step toward breaking our destructive oil addiction," said Emily Figdor, director of Environment Maine.
The regulations finalized Tuesday by the Obama administration require the fleet of new cars and trucks to average 54.5 miles per gallon in 13 years, up from 28.6 mpg at the end of last year. President Barack Obama said in a statement that the new fuel standards "represent the single most important step" his administration has taken to reduce U.S. dependence on foreign oil, a claim echoed by environmental groups in Maine.
Lisa Pohlmann, executive director of the Natural Resources Council of Maine, said the regulations will not only lesson America's oil thirst, but also cut gasoline costs in half, lower emissions of global warming pollution and create hundreds of thousands of new jobs.
"These standards show that companies, workers, government, consumer and conservation interests can work together and find solutions to the biggest problems that face us today," Pohlmann said.
Adam Lee, president of the Lee Auto Malls chain of car dealerships, said the appearance of more fuel-efficient vehicles will save Maine drivers 195 million gallons of gasoline and $610 million a year when the standards take full effect.
Lee, also board chairman of the statewide energy-conservation effort Efficiency Maine, added that the new standards will spur innovation and put people to work. He cited a study by the BlueGreen Alliance, a mix of unions and environmental organizations, that estimates 570,000 jobs could be created by the fuel efficiency standards as they spark auto industry investments and consumer savings.
Environment Maine's Figdor said Maine played a role in prompting the new standards. Long before Obama took office, California, Maine and 12 other states were developing and implementing their own state-level clean car standards, she noted.
[unable to retrieve full-text content]Every day is one of the longest you'll want an open currency trade, and many trades are for a few hours, or even a few minutes. The reason being currency traders typically use massive amounts of financial leverage in their ...
A leading teaching hospital located in the US capital, Washington D.C., has announced that it is to replace its old internal network of business phone systems with a single state of the art internet protocol (IP) telephony network. Included as part of this will be the widespread deployment of business VoIP (voice over internet protocol) phone handsets for the organisation?s 1,700 staff.
The hospital ? the Veterans Affairs Medical Center, which specialises in providing medical treatment to former US military personnel ? says it has made the decision to implement the new business VoIP system as part of a much needed overhaul of its entire communications network.
The hospital says it also intends to integrate its new IP telephony system with tablet usage amongst medical and administrative staff to further extend the mobility integral in the new business VoIP system.
Among the benefits accruing from its new IP telephony solution, says the hospital, is that voice calls, telephone conferencing and instant messaging will all now become more easily accessible, regardless of where any of the organisation?s employees are located.
It is anticipated that the hospital?s proposed IP telephony system will be ready for use by the end of the year.
The adoption of a new IP telephony and business VoIP system by the Veterans Affairs medical Center is representative of a worldwide trend among many organisations that have found that switching to IP telephony not only overcomes the inefficiencies inherent in their ageing business phone systems, but also grants them access to vastly enhanced communications processes. In many cases, it can even lead to reduced annual phone costs.
The shift to IP telephony and business VoIP is also evident among smaller companies and organisations that, although not necessarily able to afford to invest in new capital equipment, can still access IP telephony via the services of a business VoIP provider or VoIP reseller.
Get our latest blog posts delivered by email every day by adding your email address to the box below or alternatively grab the PackNet RSS feed.
If you have a positive attitude, you will find it much easier to manifest your desires, as you will be naturally giving out positive emotional thought vibrations which will attract positive things to you. Even if you are not consciously trying to manifest something, your positive attitude will naturally attract more things to be positive about and you will be one of those people who seem to attract endless good fortune. ![[ Back to EurekAlert! ]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_v0CmiAGX0pdL6DlP-C7ojH0wi571HtlMrGXNinIlSV9O6pgWt_O5tGtB19cH9RmkBDy5hjHGcAk90ItYSoupvMNXMw1aKZ7cAmfk1x1G4=s0-d){kind=small}
Public release date: 29-Aug-2012
Share ]